Press releases

New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004. More

Endo announced today that it has entered into an agreement with ProEthic to commercialize the Ketoprofen Patch developed by APR More

APR Applied Pharma Research will soon present results of the phase III efficacy trials with ketoprofen patch in the treatment of tendinites and ankle sprains at the annual meetings of the American College of Rheumatology and of the French Society of More

Sulidin® 1% LPS® Nimesulide gel receives European and US Patents for unique non-alcoholic soluble gel formulation More

The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More